Michael Pollan is the author of How to Change Your Mind (2018), the bestselling book that introduced psychedelic science to mainstream audiences and directly accelerated the modern therapeutic renaissance. A longtime contributor to The New York Times and The New Yorker, Pollan is a Research Affiliate at the UC Berkeley Center for the Science of Psychedelics. His work has played a unique role in translating peer-reviewed psychedelic research — particularly psilocybin trials at Johns Hopkins and NYU — into accessible, culturally significant narrative.
Pollan approached psychedelics as a journalist and author — a generalist with no psychopharmacology training — and that outsider perspective turned out to be precisely what the field needed in 2018. "How to Change Your Mind" synthesized the emerging clinical literature, the historical context of first-wave psychedelic research, and Pollan's own carefully documented psychedelic experiences into a book that became a cultural touchstone. It sold over a million copies, was adapted into a Netflix documentary series, and introduced the peer-reviewed evidence to an audience that would never have encountered it in academic form.
Pollan's contribution to the scientific enterprise is harder to quantify but significant. His work arrived at a critical moment — when FDA Breakthrough Therapy Designations were creating regulatory momentum but public understanding remained dominated by 1960s associations. By providing a rational, evidence-based, personally vulnerable account of psychedelic experience to mainstream readers, he helped create the cultural permission structure that allowed the science to move forward at clinical and regulatory levels.
He co-founded the UC Berkeley Center for the Science of Psychedelics in 2020, which focuses on research, training, and public education. His ongoing engagement with the field includes podcasts, essays, and public discussions that continue to bridge the gap between specialist knowledge and popular understanding — a role that serves the field's translation mission as much as any laboratory study.